{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:24:39Z","timestamp":1790490279284,"version":"4.1.0"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The innate cellular and molecular components required to mediate effective vaccination against weak tumor-associated antigens remain unclear. In this study, we used polymeric cancer vaccines incorporating different classes of adjuvants to induce tumor protection, to identify dendritic cell (DC) subsets and cytokines critical to this efficacy. Three-dimensional, porous polymer matrices loaded with tumor lysates and presenting distinct combinations of granulocyte macrophage colony-stimulating factor (GM-CSF) and various Toll-like receptor (TLR) agonists affected 70% to 90% prophylactic tumor protection in B16-F10 melanoma models. In aggressive, therapeutic B16 models, the vaccine systems incorporating GM-CSF in combination with P(I:C) or CpG-ODN induced the complete regression of solid tumors (\u226440 mm2), resulting in 33% long-term survival. Regression analysis revealed that the numbers of vaccine-resident CD8(+) DCs, plasmacytoid DCs (pDC), along with local interleukin (IL)-12, and granulocyte colony-stimulating factor (G-CSF) concentrations correlated strongly to vaccine efficacy regardless of adjuvant type. Furthermore, vaccine studies in Batf3\u2212\/\u2212 mice revealed that CD8(+) DCs are required to affect tumor protection, as vaccines in these mice were deficient in cytotoxic T lymphocytes priming and IL-12 induction in comparison with wild-type. These studies broadly demonstrate that three-dimensional polymeric vaccines provide a potent platform for prophylactic and therapeutic protection, and can be used as a tool to identify critical components of a desired immune response. Specifically, these results suggest that CD8(+) DCs, pDCs, IL-12, and G-CSF play important roles in priming effective antitumor responses with these vaccines. Cancer Res; 74(6); 1670\u201381. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-13-0777","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T22:18:35Z","timestamp":1391120315000},"page":"1670-1681","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants"],"prefix":"10.1158","volume":"74","author":[{"given":"Omar A.","family":"Ali","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Verbeke","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Johnson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Warren","family":"Sands","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Lewin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des","family":"White","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Doherty","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Dranoff","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Mooney","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Wyss Institute for Biologically Inspired Engineering, Harvard University; 2Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 4Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"key":"2022061704595284900_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"key":"2022061704595284900_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"2022061704595284900_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"2022061704595284900_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ni1420","article-title":"The innate signaling of dangers and the dangers of innate signaling","volume":"7","author":"Sansonetti","year":"2006","journal-title":"Nat Immunol"},{"key":"2022061704595284900_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature04946","article-title":"Intracellular pattern recognition receptors in the host response","volume":"442","author":"Meylan","year":"2006","journal-title":"Nature"},{"key":"2022061704595284900_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"2022061704595284900_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"Dendritic cell based vaccines","volume":"117","author":"Gilboa","year":"2007","journal-title":"J Clin Invest"},{"key":"2022061704595284900_bib8","first-page":"419","article-title":"Taking dendritic cells into medicine","volume":"49","author":"Banchereau","year":"2007","journal-title":"Nature"},{"key":"2022061704595284900_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ni1522","article-title":"Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo","volume":"8","author":"Naik","year":"2007","journal-title":"Nat Immunol"},{"key":"2022061704595284900_bib10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1204-1206","article-title":"Are dendritic cells afraid of commitment?","volume":"5","author":"O'Garra1","year":"2004","journal-title":"Nat Immunol"},{"key":"2022061704595284900_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.20030107","article-title":"The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3","volume":"2","author":"D'Amico","year":"2003","journal-title":"J Exp Med"},{"key":"2022061704595284900_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2103","article-title":"Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo","volume":"7","author":"Villadangos","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2022061704595284900_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","article-title":"Dendritic cell subsets and lineages and their functions in innate and adaptive immunity","volume":"106","author":"Liu","year":"2001","journal-title":"Cell"},{"key":"2022061704595284900_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferoun and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"2022061704595284900_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.26.021607.090254","article-title":"Migration of dendritic cell subsets and their precursors","volume":"26","author":"Randolph","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"2022061704595284900_bib16","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1073\/pnas.0601956103","article-title":"The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture","volume":"28","author":"Schnorrer","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061704595284900_bib17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20062305","article-title":"CD8\u2212 DCs induce IL-12\u2013independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS","volume":"204","author":"Skokos","year":"2007","journal-title":"J Exp Med"},{"key":"2022061704595284900_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"CD8+ but not CD8\u2212 dendritic cells cross-prime cytotoxic T cells in vivo","volume":"12","author":"Den Haana","year":"2000","journal-title":"J Exp Med"},{"key":"2022061704595284900_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/79734","article-title":"Dendritic cell regulation of TH1\u2013TH2 development","volume":"1","author":"Moser","year":"2000","journal-title":"Nat Immunol"},{"key":"2022061704595284900_bib20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"2022061704595284900_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists","volume":"13","author":"Kanzler","year":"2007","journal-title":"Nat Med"},{"key":"2022061704595284900_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.vaccine.2012.11.053","article-title":"Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy","volume":"31","author":"Hansen","year":"2013","journal-title":"Vaccine"},{"key":"2022061704595284900_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0952-7915(03)00015-3","article-title":"The use of dendritic cells in cancer immunotherapy","volume":"15","author":"Schuler","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"2022061704595284900_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI0215042","article-title":"Tumor immunotherapy: inching toward the finish line","volume":"109","author":"Curiel","year":"2002","journal-title":"J Clin Invest"},{"key":"2022061704595284900_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nmat2357","article-title":"Infection mimicking materials to program dendritic cells in situ","volume":"2","author":"Ali","year":"2009","journal-title":"Nat Mater"},{"key":"2022061704595284900_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1126\/scitranslmed.3000359","article-title":"In situ regulation of DC subsets and T Cells mediates tumor regression in mice","volume":"1","author":"Ali","year":"2009","journal-title":"Sci Transl Med"},{"key":"2022061704595284900_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E","article-title":"Open pore biodegradable matrices formed with gas foaming","volume":"42","author":"Harris","year":"1998","journal-title":"J Biomed Mater Res"},{"key":"2022061704595284900_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1015841715384","article-title":"Controlled delivery systems for proteins based on poly(lactic\/glycolic acid) microspheres","volume":"8","author":"Cohen","year":"1991","journal-title":"Pharm Res"},{"key":"2022061704595284900_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcriptionfactor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol"},{"key":"2022061704595284900_bib30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jbm.a.20036","article-title":"Fabrication and in vitro testing of polymeric delivery system for condensed DNA","volume":"67","author":"Huang","year":"2003","journal-title":"J Biomed Mater Res A"},{"key":"2022061704595284900_bib31","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jps.21176","article-title":"Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms","volume":"97","author":"Houchin","year":"2008","journal-title":"J Pharm Sci"},{"key":"2022061704595284900_bib32","first-page":"21","article-title":"Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations","volume":"39","author":"Thomas","year":"1980","journal-title":"Immunology"},{"key":"2022061704595284900_bib33","doi-asserted-by":"crossref","first-page":"13806","DOI":"10.1073\/pnas.95.23.13806","article-title":"Inhibition of interferon \u03b3 induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor","volume":"95","author":"Hodge-Dufour","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061704595284900_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"2022061704595284900_bib35","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1128\/IAI.70.10.5695-5705.2002","article-title":"Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases","volume":"70","author":"Yun","year":"2002","journal-title":"Infect Immun"},{"key":"2022061704595284900_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm.3105","article-title":"Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion","volume":"19","author":"Hailemichael","year":"2013","journal-title":"Nat Med"},{"key":"2022061704595284900_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat Med"},{"key":"2022061704595284900_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol Rev"},{"key":"2022061704595284900_bib39","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells","volume":"116","author":"Quezada","year":"2006","journal-title":"J Clin Invest"},{"key":"2022061704595284900_bib40","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1073\/pnas.0712237105","article-title":"Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients","volume":"105","author":"Hodi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061704595284900_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"key":"2022061704595284900_bib42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"},{"key":"2022061704595284900_bib43","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood.V86.6.2220.bloodjournal8662220","article-title":"Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor \u03b1 production","volume":"86","author":"Kitabayashi","year":"1995","journal-title":"Blood"},{"key":"2022061704595284900_bib44","first-page":"1024","article-title":"Serum of healthy donors receiving granulocyte colony stimulating factor induces T cell unresponsiveness","volume":"26","author":"Rutella","year":"1998","journal-title":"Exp Hematol"},{"key":"2022061704595284900_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood.V92.1.215.413k10_215_222","article-title":"Production of interleukin-10 by granulocyte colony stimulating factor mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation","volume":"92","author":"Mielcarek","year":"1998","journal-title":"Blood"},{"key":"2022061704595284900_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.165.1.566","article-title":"Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo","volume":"165","author":"Pulendran","year":"2000","journal-title":"J Immunol"},{"key":"2022061704595284900_bib47","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.immuni.2012.03.027","article-title":"GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells","volume":"36","author":"Greter","year":"2012","journal-title":"Immunity"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/6\/1670\/2716084\/1670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/6\/1670\/2716084\/1670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:16:38Z","timestamp":1655464598000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/74\/6\/1670\/599383\/Identification-of-Immune-Factors-Regulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,3,13]]},"published-print":{"date-parts":[[2014,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-13-0777","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22400741.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505655.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400738","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505655","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400738.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400741","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]}}}